CIK 0000744218
- Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133191702
- Phone
- +1 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-10 | Elston George Director | Grant or award | +6,500 | 18,500 | ||
| 2015-06-10 | Elston George Director | Grant or award · Non-Qualified Stock Option (right to buy) | +10,300 | 10,300 | ||
| 2015-06-10 | CONRAD HERBERT J Director | Grant or award | +6,500 | 18,500 | ||
| 2015-06-10 | CONRAD HERBERT J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +10,300 | 10,300 | ||
| 2015-06-10 | LIPTON KAREN SHOOS Director | Grant or award | +6,500 | 21,833 | ||
| 2015-06-10 | LIPTON KAREN SHOOS Director | Grant or award · Non-Qualified Stock Option (right to buy) | +10,300 | 10,300 | ||
| 2015-06-10 | PENNER HARRY JR Director | Grant or award | +6,500 | 21,916 | ||
| 2015-06-10 | PENNER HARRY JR Director | Grant or award · Non-Qualified Stock Option (right to buy) | +10,300 | 10,300 | ||
| 2015-06-10 | ELLBERGER LARRY Director | Grant or award | +6,500 | 33,500 | ||
| 2015-06-10 | ELLBERGER LARRY Director | Grant or award · Non-Qualified Stock Option (right to buy) | +10,300 | 10,300 | ||
| 2014-12-17 | van den Broek Richard Director | Grant or award | +2,000 | 2,000 | ||
| 2014-12-17 | van den Broek Richard Director | Grant or award · Non-Qualified Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2014-09-08 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +10,000 | $4.50 | $45K | 24,609 |
| 2014-09-08 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Incentive Stock Options | −10,000 | 17,847 | ||
| 2014-06-04 | SHANNON TIMOTHY M Director | Grant or award | +2,000 | 83,212 | ||
| 2014-06-04 | SHANNON TIMOTHY M Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,000 | 2,000 | ||
| 2014-06-04 | CONRAD HERBERT J Director | Grant or award | +2,000 | 12,000 | ||
| 2014-06-04 | CONRAD HERBERT J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,000 | 2,000 | ||
| 2014-06-04 | Elston George Director | Grant or award | +2,000 | 12,000 | ||
| 2014-06-04 | Elston George Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,000 | 2,000 |
Page 22 of 32 · 629 trades